174 related articles for article (PubMed ID: 30150163)
1. Preferences for vaccines against children's diarrheal illness among mothers in Poland and Hungary.
Poulos C; Standaert B; Sloesen B; Stryjewska I; Janitsary A; Hauber B
Vaccine; 2018 Sep; 36(40):6022-6029. PubMed ID: 30150163
[TBL] [Abstract][Full Text] [Related]
2. Parental preferences for rotavirus vaccination in young children: a discrete choice experiment.
Veldwijk J; Lambooij MS; Bruijning-Verhagen PC; Smit HA; de Wit GA
Vaccine; 2014 Oct; 32(47):6277-83. PubMed ID: 25236585
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of rotavirus vaccination in Argentina.
Urueña A; Pippo T; Betelu MS; Virgilio F; Hernández L; Giglio N; Gentile Á; Diosque M; Vizzotti C
Vaccine; 2015 May; 33 Suppl 1():A126-34. PubMed ID: 25919152
[TBL] [Abstract][Full Text] [Related]
4. Economic evaluations of rotavirus immunization for developing countries: a review of the literature.
Tu HA; Woerdenbag HJ; Kane S; Rozenbaum MH; Li SC; Postma MJ
Expert Rev Vaccines; 2011 Jul; 10(7):1037-51. PubMed ID: 21806398
[TBL] [Abstract][Full Text] [Related]
5. German travelers' preferences for travel vaccines assessed by a discrete choice experiment.
Poulos C; Curran D; Anastassopoulou A; De Moerlooze L
Vaccine; 2018 Feb; 36(7):969-978. PubMed ID: 29338877
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of rotavirus vaccination in Turkey.
Koksal T; Akelma AZ; Koksal AO; Kutukoglu I; Ozdemir O; Yuksel CN; Bozkaya D; Catal F; Sari S
J Microbiol Immunol Infect; 2017 Oct; 50(5):693-699. PubMed ID: 27107612
[TBL] [Abstract][Full Text] [Related]
7. Projected cost-effectiveness of rotavirus vaccination for children in Asia.
Podewils LJ; Antil L; Hummelman E; Bresee J; Parashar UD; Rheingans R
J Infect Dis; 2005 Sep; 192 Suppl 1():S133-45. PubMed ID: 16088797
[TBL] [Abstract][Full Text] [Related]
8. Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan.
Flem ET; Latipov R; Nurmatov ZS; Xue Y; Kasymbekova KT; Rheingans RD
J Infect Dis; 2009 Nov; 200 Suppl 1():S195-202. PubMed ID: 19817600
[TBL] [Abstract][Full Text] [Related]
9. Parental preferences for rotavirus vaccination for their children under 5 years old in China: A discrete choice experiment.
Ma W; Zhang L; Ren D; Meng X; Yin J; Sun Q
Hum Vaccin Immunother; 2023 Dec; 19(1):2179222. PubMed ID: 36794417
[TBL] [Abstract][Full Text] [Related]
10. Mothers' Preferences and Willingness to Pay for Human Papillomavirus Vaccination for Their Daughters: A Discrete Choice Experiment in Hong Kong.
Wong CKH; Man KKC; Ip P; Kwan M; McGhee SM
Value Health; 2018 May; 21(5):622-629. PubMed ID: 29753361
[TBL] [Abstract][Full Text] [Related]
11. Adolescent, parent and societal preferences and willingness to pay for meningococcal B vaccine: A Discrete Choice Experiment.
Marshall HS; Chen G; Clarke M; Ratcliffe J
Vaccine; 2016 Jan; 34(5):671-677. PubMed ID: 26740249
[TBL] [Abstract][Full Text] [Related]
12. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.
Fischer TK; Anh DD; Antil L; Cat ND; Kilgore PE; Thiem VD; Rheingans R; Tho le H; Glass RI; Bresee JS
J Infect Dis; 2005 Nov; 192(10):1720-6. PubMed ID: 16235169
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the first introduction of rotavirus vaccine in Thailand: Moving from evidence to policy.
Tharmaphornpilas P; Jiamsiri S; Boonchaiya S; Rochanathimoke O; Thinyounyong W; Tuntiwitayapun S; Guntapong R; Riewpaiboon A; Rasdjarmrearnsook AO; Glass RI
Vaccine; 2017 Feb; 35(5):796-801. PubMed ID: 28057385
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness evaluation of a rotavirus vaccination program in Argentina.
Martí SG; Alcaraz A; Valanzasca P; McMullen M; Standaert B; Garay U; Lepetic A; Gomez J
Vaccine; 2015 Oct; 33(42):5684-5690. PubMed ID: 26303875
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the Universal Immunization Programme and introduction of a rotavirus vaccine in India with IndiaSim.
Megiddo I; Colson AR; Nandi A; Chatterjee S; Prinja S; Khera A; Laxminarayan R
Vaccine; 2014 Aug; 32 Suppl 1():A151-61. PubMed ID: 25091670
[TBL] [Abstract][Full Text] [Related]
16. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.
Atherly DE; Lewis KD; Tate J; Parashar UD; Rheingans RD
Vaccine; 2012 Apr; 30 Suppl 1():A7-14. PubMed ID: 22520139
[TBL] [Abstract][Full Text] [Related]
17. Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand.
Muangchana C; Riewpaiboon A; Jiamsiri S; Thamapornpilas P; Warinsatian P
Vaccine; 2012 Apr; 30(18):2839-47. PubMed ID: 22387220
[TBL] [Abstract][Full Text] [Related]
18. Burden of rotavirus in India--is rotavirus vaccine an answer to it?
Taneja DK; Malik A
Indian J Public Health; 2012; 56(1):17-21. PubMed ID: 22684168
[TBL] [Abstract][Full Text] [Related]
19. Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.
Tu HA; Rozenbaum MH; Coyte PC; Li SC; Woerdenbag HJ; Postma MJ
Vaccine; 2012 Feb; 30(8):1521-8. PubMed ID: 22119590
[TBL] [Abstract][Full Text] [Related]
20. Rates and determinants of Rotavirus vaccine uptake among children in Italy: a cross-sectional study within the 2022 OBVIOUS* project.
La Fauci G; Soldà G; Di Valerio Z; Salussolia A; Montalti M; Scognamiglio F; Capodici A; Fantini MP; Larson HJ; Leask J; Gori D; Lenzi J
BMC Public Health; 2024 Mar; 24(1):770. PubMed ID: 38475736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
